Академический Документы
Профессиональный Документы
Культура Документы
Introduction
Why drug information is important?
Function of a clinical pharmacist
A.
Definitions
Drug information - ___________ regarding _________________
Medication information - conveys the ___________ and ______ of
C.
Longitudinal experiences
Problem-solving technique
Essential concepts of drug information
D.
Practice sites
Hospital
Academia
Community
Medical informatics
HMO, PBM, MCO
Contract DI
Poison Control
Industry
E.
2.
Services provided
The service
A.
Requestors/customer
B.
Documentation/Background
Who is calling?
Where are they calling from?
What are they requesting?
Why are they calling now?
When do they need the information by?
2.
Responding to a questions
Step 1
Step 2
Step 3
Step 4
Step 5
Step 6
Step 7
Responses:
1. Formulating a response Ask yourself Do I Know
a. The requestors name, profession, affiliation?
b. Specific patient?
c. Clear understanding of the question/problem?
d. Correct question being asked?
e. Why the question is being asked?
f. Pertinent patient history and background information?
g. Unique circumstances that generated the question?
h. What information is really needed?
i. When in the information is needed and in what format?
j. How the information I provide will actually be used?
k. How the problem or situation has been managed to date?
l. Alternative explanations or management options that have been considered or should be
further explored?
h.
i.
j.
k.
l.
3. Factors to be considered
a. Patient factors
i.
Demographics
ii.
Primary diagnosis and
medical problem list
iii.
Allergies/intolerances
iv.
End-organ function,
immune function, nutritional
statues
v.
Chief complaint
vi.
History of present
illness
vii.
Past medical history
viii.
Family history
ix.
Social history
x.
Review of body systems
xi.
Medications
xii.
Physical examination
xiii.
Laboratory tests
xiv.
Diagnostic
studies/procedures
b. Medication Factors
i.
Name
ii.
Status and availability
iii.
Physiochemical properties
iv.
Pharmacology and
pharmacodynamics
v.
Pharmacokinetics
vi.
Indications and uses
vii.
Adverse effects
viii.
Allergy/cross reactivity
ix.
Contraindications and
precautions
x.
Special populations
b. Disease factors
i.
ii.
iii.
iv.
v.
vi.
vii.
viii.
control
ix.
x.
xi.
xi.
Definition
Epidemiology
Etiology
Pathophysiology
Clinical findings
Diagnosis
Treatment
Prevention and
Risk factors
Complications
Prognosis
Mutagenicity
and carcinogenicity
xii.
Pregnancy and
lactation
xiii.
xiv.
Toxicity
Drug
interactions
xv.
Laboratory test
interactions
xvi.
xvii.
Administration
Dosage and
schedules
xviii.
xix.
Dosage forms
Monitoring
parameters
xx.
Product
preparation
xxi.
Compatibility
and stability
3.
Secondary references
Primary references
Phone/Page: ___________________
Received: _____________________
Classification: __________________________
Question: _______________________________________________________________
________________________________________________________________________
________________________________________________________________________
Background: _____________________________________________________________
________________________________________________________________________
________________________________________________________________________
Call taken by: ____
Response: _______________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
Call Back Attempts
Date
_____
_____
_____
_____
Time
_____
_____
_____
_____
Response: ____________
Initials
_____
_____
_____
_____
Results
______________________________
______________________________
______________________________
______________________________
Time: __________________________
References:
_______________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________